The ERK/MAPK pathway, with the upstream receptors and downstream regulatory elements, appeared in the enrichment results, indicating that ERK pathway provides a significant way for PCF to exert therapeutic effect on MI with depression. The gene discussed is MAPK1; the disease is major depressive disorder.